| scholarly article | Q13442814 |
| P2093 | author name string | Hanly JG | |
| Denburg JA | |||
| Carbotte RM | |||
| Denburg SD | |||
| Behmann S | |||
| P2860 | cites work | The lupus activity criteria count (LACC). | Q52684688 |
| Association between Lupus Psychosis and Antiribosomal P Protein Antibodies | Q61974605 | ||
| Cognitive impairment in systemic lupus erythematosus: a neuropsychological study of individual and group deficits | Q69061693 | ||
| Central nervous system lupus--diagnosis and treatment | Q71271677 | ||
| Measurement of Serum DNA-Binding Activity in Systemic Lupus Erythematosus | Q72531346 | ||
| The 1982 revised criteria for the classification of systemic lupus erythematosus | Q29547225 | ||
| Very late activation antigens (VLA) are human leukocyte-neuronal crossreactive cell surface antigens | Q36352224 | ||
| Neurocytotoxic antibodies in serum of patients with systemic lupus erythematosus | Q37593063 | ||
| The natural history of systemic lupus erythematosus by prospective analysis | Q39866953 | ||
| CNS lupus. | Q40242784 | ||
| Systemic lupus erythematosus. A review of 110 cases with reference to nephritis, the nervous system, infections, aseptic necrosis and prognosis | Q41006215 | ||
| An antineuronal antibody cross-reacting with erythrocytes and lymphocytes in systemic lupus erythematosus | Q41016280 | ||
| Association of IgG Anti-Brain Antibodies with Central Nervous System Dysfunction in Systemic Lupus Erythematosus | Q41045161 | ||
| Cerebrospinal fluid antibodies to neuronal cells: association with neuropsychiatric manifestations of systemic lupus erythematosus | Q41649332 | ||
| A novel neuronal antigen identified by sera from patients with systemic lupus erythematosus | Q43494836 | ||
| Mortality in systemic lupus erythematosus: the bimodal pattern revisited | Q43971969 | ||
| Cerebrospinal fluid immunoglobulins and neuronal antibodies in neuropsychiatric systemic lupus erythematosus and related conditions | Q48222363 | ||
| Autoantibodies in the cerebrospinal fluid of patients with systemic lupus erythematosus | Q48303518 | ||
| Prevalence of cognitive impairment in systemic lupus erythematosus | Q48337331 | ||
| Antineuronal antibodies in neuropsychiatric systemic lupus erythematosus | Q48473651 | ||
| The pathogenesis of central nervous system manifestations of systemic lupus erythematosus | Q48925433 | ||
| Antineuronal antibodies in brain tissue of patient with systemic lupus erythematosus | Q48955928 | ||
| P433 | issue | 767 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | neuropsychiatric systemic lupus erythematosus | Q9358981 |
| P304 | page(s) | 622-627 | |
| P577 | publication date | 1989-09-01 | |
| P1433 | published in | Postgraduate Medical Journal | Q7234294 |
| P1476 | title | The association between sequential changes in serum antineuronal antibodies and neuropsychiatric systemic lupus erythematosus | |
| P478 | volume | 65 |
| Q41247745 | Antibodies to protein P in systemic lupus erythematosus |
| Q70578706 | Assessment of cognitive function in patients with systemic lupus erythematosus |
| Q48115169 | Brain reactive autoantibodies and cognitive impairment in systemic lupus erythematosus |
| Q48334054 | Brain synaptosomal antibodies in systemic lupus erythematosus |
| Q41002727 | Central nervous system (CNS) involvement in SLE. The diagnostic role of antibodies to neuronal antigens |
| Q40827014 | Cognitive changes in systemic lupus erythematosus |
| Q35625220 | Cognitive dysfunction and antiphospholipid antibodies in systemic lupus erythematosus |
| Q36434125 | Cognitive dysfunction in the patient with antiphospholipid antibodies: considerations for cause and treatment |
| Q31166031 | Diagnosis and pathogenesis of CNS lupus |
| Q40929944 | Nervous system lupus: pathogenesis and rationale for therapy |
| Q37768381 | Quality-of-life measurements versus disease activity in systemic lupus erythematosus |
Search more.